anti-Herpes Simplex Virus I, Glycoprotein G1 antibody product blog
Tags: Antibody; Monoclonal Antibody; Herpes Simplex Virus I, Glycoprotein G1; anti-Herpes Simplex Virus I, Glycoprotein G1 antibody;
The Herpes Simplex Virus I, Glycoprotein G1 n/a (Catalog #MBS609058) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Herpes Simplex Virus I, Glycoprotein G1 can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).Suitable for use in ELISA and Western Blot. Researchers should empirically determine the suitability of the Herpes Simplex Virus I, Glycoprotein G1 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Herpes simplex virus type 1 (HSV1) is usually associated with infections of the lips, mouth, and face. It is the most common herpes simplex virus and is usually acquired in childhood. HSV-1 often causes lesions inside the mouth such as cold sores (fever blisters) and is transmitted by contact with infected saliva. Glycoprotein G is suggested to contribute to viral entry through apical surfaces of polarized cells.
Immunogen: Herpes Simplex Virus I, Glycoprotein G (HSV I, gG-1). In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Herpes Simplex Virus I, Glycoprotein G1 are readily searchable from our website. Different antibodies against the same target such as Herpes Simplex Virus I, Glycoprotein G1 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.